Purpose
to evaluate the effectiveness of Pfizer and J&J SARS-CoV-2 vaccines against laboratory-confirmed COVID-19 hospitalisation among risk groups targeted for vaccination
Grantee
Division
Global Health
Date
AUGUST 2021
Region served
AFRICA
Committed amount
$828,259
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
29
Grantee location
Johannesburg, GP, South Africa
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.